Abstract WE563: Loneliness, Social Support and Cardiovascular Risk Among Midlife Adults: A Population-Based Study Using the 2023 Behavioral Risk Factor Surveillance System.

D Dennis Tsagli (Washington University in St Louis, St Louis, Missouri, United States) E Estherla Twene (Washington University in St Louis, St Louis, Missouri, United States) J Junu Rana Magar (Washington University in St Louis, St Louis, Missouri, United States) N Nana Afia Gyapong (London School of Hygiene and Tropical Medicine, London, United Kingdom) B Bethel Alemayehu (Washington University in St Louis, St Louis, Missouri, United States) R Reuben Odai (KU School of Medicine-Wichita, Wichita, Kansas, United States) M Manuel Agyei (Washington University in St Louis, St Louis, Missouri, United States) L Lindsey Filiatreau (Washington University in St Louis, St Louis, Missouri, United States)

Abstract

Introduction: Loneliness and low social support are potential risk factors for cardiovascular disease (CVD). Both are linked to stress-related neuroendocrine and inflammatory changes, but population-level evidence linking these exposures to CVD remains limited. This study investigates how loneliness and social support interact to contribute to cardiovascular risk among U.S. adults aged 45–64, a critical window for CVD prevention. Methods: We used 2023 Behavioral Risk Factor Surveillance System data from adults aged 45-64 to assess how the joint exposure of loneliness and social support were associated with CVD risk. Both variables were dichotomized and combined into four exposure groups. Elevated CVD risk was defined as ≥ 3 of six of AHA Life’s Essential 8 factors: smoking, physical activity, obesity, hypertension, hypercholesterolemia, and diabetes. Multiple imputation was used to address missing data, and survey weights were applied. Weighted prevalence ratios were quantified using adjusted Poisson regression models with a robust variance estimator and 95% confidence intervals were used to compare outcomes across exposure groups. Adjusted models controlled for age, sex, race and education. Results: Overall, 67,541,291 individuals were included; 26% of whom reported loneliness and 17% reported low social support. Approximately, 10% of individuals reported high loneliness and low support. CVD risk factors were disproportionately prevalent among lonely and low social support groups. For example, diabetes prevalence was 16% among lonely + low support adults vs. 7% among those not lonely + high support. In adjusted models, the prevalence of elevated CVD risk among adults who were lonely and had low social support was 1.36 times (95% CI 1.15–1.61) the prevalence among those with high support who weren’t lonely. Individuals who were lonely but had high support also had a higher prevalence of elevated CVD risk (PR 1.23, 95% CI 0.98–1.54), while those who were not lonely but had low support exhibited modestly higher prevalence of heightened CVD risk (PR 1.14, 95% CI 0.96–1.32). Conclusion: Our findings add nationally representative evidence that loneliness and low social support, particularly in combination, are associated with elevated CVD risk in midlife. Addressing loneliness and strengthening social support through public health interventions that promote peer support and social cohesion are needed to mitigate suboptimal CVD outcomes and promote cardiovascular equity.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue Suppl_1
Published March 24, 2026
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (8)

D

Dennis Tsagli

Washington University in St Louis, St Louis, Missouri, United States

E

Estherla Twene

Washington University in St Louis, St Louis, Missouri, United States

J

Junu Rana Magar

Washington University in St Louis, St Louis, Missouri, United States

N

Nana Afia Gyapong

London School of Hygiene and Tropical Medicine, London, United Kingdom

B

Bethel Alemayehu

Washington University in St Louis, St Louis, Missouri, United States

R

Reuben Odai

KU School of Medicine-Wichita, Wichita, Kansas, United States

M

Manuel Agyei

Washington University in St Louis, St Louis, Missouri, United States

L

Lindsey Filiatreau

Washington University in St Louis, St Louis, Missouri, United States